» Articles » PMID: 26668025

Association of APOL1 Genotype with Renal Histology Among Black HIV-Positive Patients Undergoing Kidney Biopsy

Overview
Specialty Nephrology
Date 2015 Dec 16
PMID 26668025
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Prior studies have shown that the APOL1 risk alleles are associated with a greater risk of HIV-associated nephropathy and FSGS among blacks who are HIV positive. We sought to determine whether the APOL1 high-risk genotype incrementally improved the prediction of these underlying lesions beyond conventional clinical factors.

Design, Setting, Participants, & Measurements: In a cross-sectional study, we analyzed data from 203 blacks who are HIV positive, underwent kidney biopsies between 1996 and 2011, and were genotyped for the APOL1 G1 and G2 alleles. Predictive logistic regression models with conventional clinical factors were compared with those that also included APOL1 genotype using receiver-operating curves and bootstrapping analyses with crossvalidation.

Results: The addition of APOL1 genotype to HIV-related risk factors for kidney disease in a predictive model improved the prediction of non-HIV-associated nephropathy FSGS, specifically, increasing the c statistic from 0.65 to 0.74 (P=0.04). Although two risk alleles were significantly associated with higher odds of HIV-associated nephropathy, APOL1 genotype did not add incrementally to the prediction of this specific histopathology.

Conclusions: APOL1 genotype may provide additional diagnostic information to traditional clinical variables in predicting underlying FSGS spectrum lesions in blacks who are HIV positive. In contrast, although APOL1 risk genotype predicts HIV-associated nephropathy, it lacked a high c statistic sufficient for discrimination to eliminate the role of kidney biopsy in the clinical care of blacks who are HIV positive with nephrotic proteinuria or unexplained kidney disease.

Citing Articles

The changing landscape of HIV-associated kidney disease.

Diana N, Naicker S Nat Rev Nephrol. 2024; 20(5):330-346.

PMID: 38273026 DOI: 10.1038/s41581-023-00801-1.


HIV-Associated Nephropathy in 2022.

Rivera F, Ansay M, Golbin J, Alfonso P, Mangubat G, Menghrajani R Glomerular Dis. 2023; 3(1):1-11.

PMID: 36816427 PMC: 9936764. DOI: 10.1159/000526868.


Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.

Waziri B, Raji Y, Ekrikpo U, Naicker S J Nephrol. 2022; 36(4):1119-1134.

PMID: 36510118 DOI: 10.1007/s40620-022-01512-9.


Prognostic model for nephrotoxicity among HIV-positive Zambian adults receiving tenofovir disoproxil fumarate-based antiretroviral therapy.

Chabala F, Siew E, Mutale W, Mulenga L, Mweemba A, Goma F PLoS One. 2021; 16(7):e0252768.

PMID: 34252117 PMC: 8274919. DOI: 10.1371/journal.pone.0252768.


Apolipoprotein L1 and mechanisms of kidney disease susceptibility.

Bruggeman L, Sedor J, OToole J Curr Opin Nephrol Hypertens. 2021; 30(3):317-323.

PMID: 33767059 PMC: 8211384. DOI: 10.1097/MNH.0000000000000704.


References
1.
Monajemi H, Fontijn R, Pannekoek H, Horrevoets A . The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics. 2002; 79(4):539-46. DOI: 10.1006/geno.2002.6729. View

2.
Lucas G, Lau B, Atta M, Fine D, Keruly J, Moore R . Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008; 197(11):1548-57. PMC: 2553209. DOI: 10.1086/587994. View

3.
Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View

4.
Genovese G, Friedman D, Ross M, Lecordier L, Uzureau P, Freedman B . Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329(5993):841-5. PMC: 2980843. DOI: 10.1126/science.1193032. View

5.
Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A . Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010; 128(3):345-50. PMC: 2921485. DOI: 10.1007/s00439-010-0861-0. View